Benjamin Besse: Time to change our practice and give our IOs in the morning?

Benjamin Besse, Head of Clinical Research at Gustave Roussy, shared on Twitter:

“Accumulative publications showing that immunotherapy is more potent when given early in the day. Time to change our practice and give our IOs in the morning? At least until evidence of a circadian biology supporting the hypothesis & availability of data from phase III trials?”

Source: Benjamin Besse/Twitter